Jeuveau Treatment of Glabellar Lines Using OLD Versus COLD
Not yet recruiting
Evolus, Inc.
Early Phase 1
2021-11-01
This is a blinded, randomized study in the US to compare the duration response of two
different concentrations of Jeuveau in healthy female subjects with moderate to severe
dynamic glabellar lines on maximum frown.
Jeuveau Treatment of Glabellar Lines Using OLD Versus COLD
Not yet recruiting
Clinical Testing of Beverly Hills
Early Phase 1
2021-11-01
This is a blinded, randomized study in the US to compare the duration response of two
different concentrations of Jeuveau in healthy female subjects with moderate to severe
dynamic glabellar lines on maximum frown.
Evaluation of Four Injectable Neuromodulators in the Glabella Area Glabella Area
Not yet recruiting
University of Pennsylvania
N/A
2022-01-15
The purpose of the study is to use 3D imaging to evaluate the effects of four FDA approved
neuromodulators on facial lines, wrinkles and animation. Participation is available to women
who have never had a cosmetic procedure above the malar region nor a treatment with a
neuromodulator within 12 months. All subjects will undergo 3D imaging using the VECTRA M3
(Canfield Scientific, Inc, Fairfield, NJ) prior to treatment with a neuromodulator in order
to determine their baseline dimensions. Imaging will be repeated post injection to determine
change over time.
Study to Demonstrate Safety and Duration of Effect of 40 Units of PrabotulinumtoxinA-xvfs to Treat Glabellar Lines
Recruiting
ethica Clinical Research Inc.
Phase 2
2022-03-30
The purpose of this study is to demonstrate the safety and duration of effect of 40 Units of
prabotulinumtoxinA-xvfs (Jeuveau®) in providing temporary improvement in the appearance of
moderate to severe glabellar lines (frown lines, which are the vertical lines that develop
between the eyebrows) in adult participants. It will also determine if the duration of effect
of 40 Units of Jeuveau® is greater than that of 20 Units of Jeuveau® and 20 Units of Botox®
Cosmetic.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
